Binding Site is committed to improving patient lives worldwide through education, collaboration and innovation. Discover how your patients could benefit from Binding Site’s portfolio of products aimed at improving the diagnosis and management of blood cancers such as Multiple Myeloma and Immunodeficiency diseases.
Binding Site products have been on the market for over 25 years and our serum Free Light Chain test (Freelite) is recommended by international and national guidelines for diagnosis and monitoring of Multiple Myeloma. Our expertise in Immune Disorders has also led to the innovation of products aimed at the early identification, confirmation and management of various Immunodeficiency conditions.
Come and see us at stand C24 to find out more about our products.